Target intelligence / Profile preview

Polyadenylate-binding protein 1 (PABPC1)

Target
PABPC1
Molecular classification
RNA-binding protein, Ribonucleoprotein complex component
01

Overview

Polyadenylate-binding protein 1 (PABPC1) is an RNA-binding protein that binds specifically to the poly(A) tail at the 3' end of eukaryotic messenger RNAs. It plays a central role in regulating various aspects of mRNA metabolism, including stability, transport between nucleus and cytoplasm, translation efficiency, and degradation. PABPC1 contains four RNA recognition motifs (RRMs) that mediate its binding to polyadenylated RNA sequences with high specificity. In addition to its interaction with RNA, it has a C-terminal MLLE/PABC domain that mediates interactions with regulatory proteins such as eukaryotic release factor 3 (eRF3), PAIP1, PAIP2, and others involved in translational control. While essential for normal cell function and implicated in processes like stress granule formation or viral infection response, PABPC1 itself is not considered a classical therapeutic target such as an enzyme or receptor. The submitted name "Ribonucleoprotein complex containing polyadenylate binding protein‑1" is overly broad; the canonical molecular entity relevant for structured data is "Polyadenylate-binding protein 1" (PABPC1).

Other names
Poly(A)-binding protein cytoplasmic 1PABP1Cytosolic poly(A)-binding protein 1
02

Biological functions

mRNA stabilizationRegulation of mRNA translationmRNA transport and export from nucleus to cytoplasmPrevention of nonsense-mediated mRNA decay (NMD)Promotion of translation initiation
03

Disease associations

Other (no direct, well-established role as a therapeutic target in major disease classes; may be involved in viral infection and cellular stress responses)

Beyond the preview

Go deeper on Polyadenylate-binding protein 1 (PABPC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polyadenylate-binding protein 1 (PABPC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call